Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01720511 · ClinicalTrials.gov registry record · NA

Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation

A NA study of Type 2 Diabetic, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT01720511 is a NA study of Type 2 Diabetic that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01720511, a NA study of Type 2 Diabetic, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to demonstrate the effect of purple rice on post-prandial glucose and insulin. The purple color is due, like red wine grapes, mainly to the anthocyanins. The safety and tolerability of purple rice is similar to white or brown rice, but contains the purple elements common to other foods like grapes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Purple Rice
  • DIETARY_SUPPLEMENT Brown Rice

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2012-09
Est. Completion 2015-10
Phase NA

What the Registry Record Tells You About NCT01720511

The ClinicalTrials.gov registry entry for NCT01720511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetic appearing as the primary indexed condition, and to 2 interventions - of which Purple Rice is the first listed.

NCT01720511 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT01720511 about?

NCT01720511 is a clinical study titled "Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation". This is a pilot study to demonstrate the effect of purple rice on post-prandial glucose and insulin. The purple color is due, like red wine grapes, mainly to the anthocyanins. The safety and tolerability of purple rice is similar to white or brown rice, but contains the purple elements common to oth...

What is the current status of trial NCT01720511?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-09. Estimated completion is 2015-10.

What conditions does trial NCT01720511 study?

This clinical trial studies the following conditions: Type 2 Diabetic.

What interventions are being tested in trial NCT01720511?

The interventions under investigation include: Purple Rice (DIETARY_SUPPLEMENT), Brown Rice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01720511?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01720511 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.